News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

Lilly partners with Samsung to boost COVID-19 antibody manufacturing amid supply concerns

A week after Eli Lilly won an FDA emergency authorization for its COVID-19 antibody, concerns over limited supplies are already popping up, and the company is bringing in an experienced manufacturing
2020/11/6
Alkermes flops FDA's 'remote review' at manufacturing site for schizophrenia, bipolar disorder drug

The COVID-19 pandemic has changed the way the pharmaceutical industry works, crucially in how regulators inspect key manufacturing sites. To skirt around lockdowns, the FDA has started conducting "re
2020/11/5
Buffett's Berkshire bets big on AbbVie, Bristol Myers, Merck, Pfizer as COVID-19 drives healthcare investment

As the COVID-19 pandemic fuels a global interest in healthcare, many deep-pocketed investors havediverted their money to the sector. Billionaire Warren Buffett is among those who have now doubled dow
2020/11/4
CureVac, EU ink supply deal for up to 405M doses of mRNA coronavirus shot: Reuters

With mRNA-based coronavirus vaccines from Pfizer and Moderna showing promise in late-stagestudies, another companyworking on a midstage mRNA candidatehas inked a large supply deal with the EU. CureVa
2020/11/2
Moderna's COVID-19 vaccine is stable in refrigerators for 30 days, easing concerns around large-scale rollout

A week after Pfizer posted impressive early coronavirus vaccine efficacy numbers, Moderna took the spotlight early Monday withimpressive findings of its own. But separatefrom itsbigannouncement, the
2020/11/2
Pharmaceutical Excipient Market Research Report by Type - Global Forecast to 2025 - Cumulative Impact of COVID-19

- The Global Pharmaceutical Excipient Market is expected to grow from USD 6,775.32 Million in 2019 to USD 9,453.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.70%.- On the
2020/10/26
CDC's distribution road map, safety monitoring plans plus other takeaways from FDA's big COVID-19 vaccine meeting

In less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic. Concerns remain, though, and, amid that backdrop, top gov
2020/10/23
HHS Secretary Azar discussed firing FDA chief Hahn after showdown over COVID-19 vaccine guidance: Politico

President Donald Trump touted a COVID-19 vaccine ready for Election Day, and behind the scenes, his officials tried to make it happen. But despite intense pressure, the FDA publicly rolled out strict
2020/10/22
Moderna, now wrapped on phase 3 enrollment, touts diversity of vaccine trial participants

Moderna is one step closer to a COVID-19 vaccine. Racing ahead with its candidate, mRNA-1273, the biotech has nowfinishedenrolling the 30,000 participants needed for its late-stage trial. Testing the
2020/10/22
Lonza plots $93M expansion to capsule manufacturing, adding billions of doses per year

When CDMO Lonza shelled out $5.5 billion for capsule maker Capsugel in 2017, it made a big bet the booming capsule market would drive revenue. Now, with demand continuing to grow, Lonza is putting an
2020/10/21

Excipients